Global Prescription Pain Relievers Market Research Report 2023

December 2023 | 95 pages | ID: G5638F2025B2EN
QYResearch

Abstracts

According to QYResearch’s new survey, global Prescription Pain Relievers market is projected to reach US$ 42600 million in 2029, increasing from US$ 34290 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prescription Pain Relievers market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Prescription Pain Relievers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• Pfizer
• GSK
• Grunenthal
• Bayer
• Sanofi
• Eli Lilly
• AstraZeneca
• Endo
• Merck
• Depomed
• Yunnan Baiyao
• Teva
• J&J
• Allergan
• Purdue

Segment by Type

• Generic Opioids
• Branded Opioids
• NSAIDs
• Others

Segment by Application

• Hospitals
• Clinics
• Drugstores

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

The Prescription Pain Relievers report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Prescription Pain Relievers Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Generic Opioids
  1.2.3 Branded Opioids
  1.2.4 NSAIDs
  1.2.5 Others
1.3 Market by Application
  1.3.1 Global Prescription Pain Relievers Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Drugstores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Prescription Pain Relievers Market Perspective (2018-2029)
2.2 Prescription Pain Relievers Growth Trends by Region
  2.2.1 Global Prescription Pain Relievers Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Prescription Pain Relievers Historic Market Size by Region (2018-2023)
  2.2.3 Prescription Pain Relievers Forecasted Market Size by Region (2024-2029)
2.3 Prescription Pain Relievers Market Dynamics
  2.3.1 Prescription Pain Relievers Industry Trends
  2.3.2 Prescription Pain Relievers Market Drivers
  2.3.3 Prescription Pain Relievers Market Challenges
  2.3.4 Prescription Pain Relievers Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Prescription Pain Relievers Players by Revenue
  3.1.1 Global Top Prescription Pain Relievers Players by Revenue (2018-2023)
  3.1.2 Global Prescription Pain Relievers Revenue Market Share by Players (2018-2023)
3.2 Global Prescription Pain Relievers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prescription Pain Relievers Revenue
3.4 Global Prescription Pain Relievers Market Concentration Ratio
  3.4.1 Global Prescription Pain Relievers Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Prescription Pain Relievers Revenue in 2022
3.5 Prescription Pain Relievers Key Players Head office and Area Served
3.6 Key Players Prescription Pain Relievers Product Solution and Service
3.7 Date of Enter into Prescription Pain Relievers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PRESCRIPTION PAIN RELIEVERS BREAKDOWN DATA BY TYPE

4.1 Global Prescription Pain Relievers Historic Market Size by Type (2018-2023)
4.2 Global Prescription Pain Relievers Forecasted Market Size by Type (2024-2029)

5 PRESCRIPTION PAIN RELIEVERS BREAKDOWN DATA BY APPLICATION

5.1 Global Prescription Pain Relievers Historic Market Size by Application (2018-2023)
5.2 Global Prescription Pain Relievers Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Prescription Pain Relievers Market Size (2018-2029)
6.2 North America Prescription Pain Relievers Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prescription Pain Relievers Market Size by Country (2018-2023)
6.4 North America Prescription Pain Relievers Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Prescription Pain Relievers Market Size (2018-2029)
7.2 Europe Prescription Pain Relievers Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prescription Pain Relievers Market Size by Country (2018-2023)
7.4 Europe Prescription Pain Relievers Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Prescription Pain Relievers Market Size (2018-2029)
8.2 Asia-Pacific Prescription Pain Relievers Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prescription Pain Relievers Market Size by Region (2018-2023)
8.4 Asia-Pacific Prescription Pain Relievers Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Prescription Pain Relievers Market Size (2018-2029)
9.2 Latin America Prescription Pain Relievers Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prescription Pain Relievers Market Size by Country (2018-2023)
9.4 Latin America Prescription Pain Relievers Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Prescription Pain Relievers Market Size (2018-2029)
10.2 Middle East & Africa Prescription Pain Relievers Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prescription Pain Relievers Market Size by Country (2018-2023)
10.4 Middle East & Africa Prescription Pain Relievers Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Pfizer
  11.1.1 Pfizer Company Detail
  11.1.2 Pfizer Business Overview
  11.1.3 Pfizer Prescription Pain Relievers Introduction
  11.1.4 Pfizer Revenue in Prescription Pain Relievers Business (2018-2023)
  11.1.5 Pfizer Recent Development
11.2 GSK
  11.2.1 GSK Company Detail
  11.2.2 GSK Business Overview
  11.2.3 GSK Prescription Pain Relievers Introduction
  11.2.4 GSK Revenue in Prescription Pain Relievers Business (2018-2023)
  11.2.5 GSK Recent Development
11.3 Grunenthal
  11.3.1 Grunenthal Company Detail
  11.3.2 Grunenthal Business Overview
  11.3.3 Grunenthal Prescription Pain Relievers Introduction
  11.3.4 Grunenthal Revenue in Prescription Pain Relievers Business (2018-2023)
  11.3.5 Grunenthal Recent Development
11.4 Bayer
  11.4.1 Bayer Company Detail
  11.4.2 Bayer Business Overview
  11.4.3 Bayer Prescription Pain Relievers Introduction
  11.4.4 Bayer Revenue in Prescription Pain Relievers Business (2018-2023)
  11.4.5 Bayer Recent Development
11.5 Sanofi
  11.5.1 Sanofi Company Detail
  11.5.2 Sanofi Business Overview
  11.5.3 Sanofi Prescription Pain Relievers Introduction
  11.5.4 Sanofi Revenue in Prescription Pain Relievers Business (2018-2023)
  11.5.5 Sanofi Recent Development
11.6 Eli Lilly
  11.6.1 Eli Lilly Company Detail
  11.6.2 Eli Lilly Business Overview
  11.6.3 Eli Lilly Prescription Pain Relievers Introduction
  11.6.4 Eli Lilly Revenue in Prescription Pain Relievers Business (2018-2023)
  11.6.5 Eli Lilly Recent Development
11.7 AstraZeneca
  11.7.1 AstraZeneca Company Detail
  11.7.2 AstraZeneca Business Overview
  11.7.3 AstraZeneca Prescription Pain Relievers Introduction
  11.7.4 AstraZeneca Revenue in Prescription Pain Relievers Business (2018-2023)
  11.7.5 AstraZeneca Recent Development
11.8 Endo
  11.8.1 Endo Company Detail
  11.8.2 Endo Business Overview
  11.8.3 Endo Prescription Pain Relievers Introduction
  11.8.4 Endo Revenue in Prescription Pain Relievers Business (2018-2023)
  11.8.5 Endo Recent Development
11.9 Merck
  11.9.1 Merck Company Detail
  11.9.2 Merck Business Overview
  11.9.3 Merck Prescription Pain Relievers Introduction
  11.9.4 Merck Revenue in Prescription Pain Relievers Business (2018-2023)
  11.9.5 Merck Recent Development
11.10 Depomed
  11.10.1 Depomed Company Detail
  11.10.2 Depomed Business Overview
  11.10.3 Depomed Prescription Pain Relievers Introduction
  11.10.4 Depomed Revenue in Prescription Pain Relievers Business (2018-2023)
  11.10.5 Depomed Recent Development
11.11 Yunnan Baiyao
  11.11.1 Yunnan Baiyao Company Detail
  11.11.2 Yunnan Baiyao Business Overview
  11.11.3 Yunnan Baiyao Prescription Pain Relievers Introduction
  11.11.4 Yunnan Baiyao Revenue in Prescription Pain Relievers Business (2018-2023)
  11.11.5 Yunnan Baiyao Recent Development
11.12 Teva
  11.12.1 Teva Company Detail
  11.12.2 Teva Business Overview
  11.12.3 Teva Prescription Pain Relievers Introduction
  11.12.4 Teva Revenue in Prescription Pain Relievers Business (2018-2023)
  11.12.5 Teva Recent Development
11.13 J&J
  11.13.1 J&J Company Detail
  11.13.2 J&J Business Overview
  11.13.3 J&J Prescription Pain Relievers Introduction
  11.13.4 J&J Revenue in Prescription Pain Relievers Business (2018-2023)
  11.13.5 J&J Recent Development
11.14 Allergan
  11.14.1 Allergan Company Detail
  11.14.2 Allergan Business Overview
  11.14.3 Allergan Prescription Pain Relievers Introduction
  11.14.4 Allergan Revenue in Prescription Pain Relievers Business (2018-2023)
  11.14.5 Allergan Recent Development
11.15 Purdue
  11.15.1 Purdue Company Detail
  11.15.2 Purdue Business Overview
  11.15.3 Purdue Prescription Pain Relievers Introduction
  11.15.4 Purdue Revenue in Prescription Pain Relievers Business (2018-2023)
  11.15.5 Purdue Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Prescription Pain Relievers Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Generic Opioids
Table 3. Key Players of Branded Opioids
Table 4. Key Players of NSAIDs
Table 5. Key Players of Others
Table 6. Global Prescription Pain Relievers Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Prescription Pain Relievers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Prescription Pain Relievers Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prescription Pain Relievers Market Share by Region (2018-2023)
Table 10. Global Prescription Pain Relievers Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Prescription Pain Relievers Market Share by Region (2024-2029)
Table 12. Prescription Pain Relievers Market Trends
Table 13. Prescription Pain Relievers Market Drivers
Table 14. Prescription Pain Relievers Market Challenges
Table 15. Prescription Pain Relievers Market Restraints
Table 16. Global Prescription Pain Relievers Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prescription Pain Relievers Market Share by Players (2018-2023)
Table 18. Global Top Prescription Pain Relievers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Pain Relievers as of 2022)
Table 19. Ranking of Global Top Prescription Pain Relievers Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Prescription Pain Relievers Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prescription Pain Relievers Product Solution and Service
Table 23. Date of Enter into Prescription Pain Relievers Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prescription Pain Relievers Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prescription Pain Relievers Revenue Market Share by Type (2018-2023)
Table 27. Global Prescription Pain Relievers Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Prescription Pain Relievers Revenue Market Share by Type (2024-2029)
Table 29. Global Prescription Pain Relievers Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prescription Pain Relievers Revenue Market Share by Application (2018-2023)
Table 31. Global Prescription Pain Relievers Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Prescription Pain Relievers Revenue Market Share by Application (2024-2029)
Table 33. North America Prescription Pain Relievers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Prescription Pain Relievers Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Prescription Pain Relievers Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Prescription Pain Relievers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Prescription Pain Relievers Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Prescription Pain Relievers Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Prescription Pain Relievers Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Prescription Pain Relievers Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Prescription Pain Relievers Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Prescription Pain Relievers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Prescription Pain Relievers Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prescription Pain Relievers Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Prescription Pain Relievers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Prescription Pain Relievers Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Prescription Pain Relievers Market Size by Country (2024-2029) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Prescription Pain Relievers Product
Table 51. Pfizer Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. GSK Company Detail
Table 54. GSK Business Overview
Table 55. GSK Prescription Pain Relievers Product
Table 56. GSK Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 57. GSK Recent Development
Table 58. Grunenthal Company Detail
Table 59. Grunenthal Business Overview
Table 60. Grunenthal Prescription Pain Relievers Product
Table 61. Grunenthal Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 62. Grunenthal Recent Development
Table 63. Bayer Company Detail
Table 64. Bayer Business Overview
Table 65. Bayer Prescription Pain Relievers Product
Table 66. Bayer Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Sanofi Company Detail
Table 69. Sanofi Business Overview
Table 70. Sanofi Prescription Pain Relievers Product
Table 71. Sanofi Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Eli Lilly Company Detail
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Prescription Pain Relievers Product
Table 76. Eli Lilly Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. AstraZeneca Company Detail
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Prescription Pain Relievers Product
Table 81. AstraZeneca Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Endo Company Detail
Table 84. Endo Business Overview
Table 85. Endo Prescription Pain Relievers Product
Table 86. Endo Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 87. Endo Recent Development
Table 88. Merck Company Detail
Table 89. Merck Business Overview
Table 90. Merck Prescription Pain Relievers Product
Table 91. Merck Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Depomed Company Detail
Table 94. Depomed Business Overview
Table 95. Depomed Prescription Pain Relievers Product
Table 96. Depomed Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 97. Depomed Recent Development
Table 98. Yunnan Baiyao Company Detail
Table 99. Yunnan Baiyao Business Overview
Table 100. Yunnan Baiyao Prescription Pain Relievers Product
Table 101. Yunnan Baiyao Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 102. Yunnan Baiyao Recent Development
Table 103. Teva Company Detail
Table 104. Teva Business Overview
Table 105. Teva Prescription Pain Relievers Product
Table 106. Teva Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 107. Teva Recent Development
Table 108. J&J Company Detail
Table 109. J&J Business Overview
Table 110. J&J Prescription Pain Relievers Product
Table 111. J&J Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 112. J&J Recent Development
Table 113. Allergan Company Detail
Table 114. Allergan Business Overview
Table 115. Allergan Prescription Pain Relievers Product
Table 116. Allergan Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 117. Allergan Recent Development
Table 118. Purdue Company Detail
Table 119. Purdue Business Overview
Table 120. Purdue Prescription Pain Relievers Product
Table 121. Purdue Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 122. Purdue Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Prescription Pain Relievers Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Prescription Pain Relievers Market Share by Type: 2022 VS 2029
Figure 3. Generic Opioids Features
Figure 4. Branded Opioids Features
Figure 5. NSAIDs Features
Figure 6. Others Features
Figure 7. Global Prescription Pain Relievers Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Prescription Pain Relievers Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Drugstores Case Studies
Figure 12. Prescription Pain Relievers Report Years Considered
Figure 13. Global Prescription Pain Relievers Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Prescription Pain Relievers Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Prescription Pain Relievers Market Share by Region: 2022 VS 2029
Figure 16. Global Prescription Pain Relievers Market Share by Players in 2022
Figure 17. Global Top Prescription Pain Relievers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Pain Relievers as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Prescription Pain Relievers Revenue in 2022
Figure 19. North America Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Prescription Pain Relievers Market Share by Country (2018-2029)
Figure 21. United States Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Prescription Pain Relievers Market Share by Country (2018-2029)
Figure 25. Germany Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Prescription Pain Relievers Market Share by Region (2018-2029)
Figure 33. China Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Prescription Pain Relievers Market Share by Country (2018-2029)
Figure 41. Mexico Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Prescription Pain Relievers Market Share by Country (2018-2029)
Figure 45. Turkey Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Prescription Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 48. GSK Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 49. Grunenthal Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 50. Bayer Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 52. Eli Lilly Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 53. AstraZeneca Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 54. Endo Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 56. Depomed Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 57. Yunnan Baiyao Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 58. Teva Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 59. J&J Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 60. Allergan Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 61. Purdue Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed